Printer Friendly
The Free Library
19,607,050 articles and books
Member login
User name  
Password 
 
Join us Forgot password?

Dendrite Announces Multi-Country Business.


Business Editors

MORRISTOWN, N.J.--(BUSINESS WIRE)--Nov. 6, 2001

Celltech Pharmaceuticals, U.S.

Pfizer, Colombia, Ecuador, and Venezuela

Sanofi Synthelabo, Argentina, Colombia, Venezuela

Ashfield Healthcare Ltd., U.K.

Dendrite dendrite: see nervous system; synapse.  (NASDAQ/NMS: DRTE DRTE Defence Research Telecommunications Establishment ), the visionary innovator in global pharmaceutical technology, today announced several recent international contracts in the company's United States United States, officially United States of America, republic (2005 est. pop. 295,734,000), 3,539,227 sq mi (9,166,598 sq km), North America. The United States is the world's third largest country in population and the fourth largest country in area. , European, and Latin American markets worth more than $7 million and involving over 1,000 sales representatives.

Celltech Pharmaceuticals

Celltech Pharmaceuticals, one of Europe's largest biopharmaceutical companies, is converting from a paper-based system to Dendrite's web-enabled solutions. Celltech will deploy WebForce(TM) 1.5, a comprehensive, web-enabled product suite, for its U.S.-based sales representatives, and ForceMC(TM) for its account-based management team. ForceMC(TM) is Dendrite's premium, highly configurable sales force solution designed specifically for the requirements of managed care account-based pharmaceutical sales reps.

Celltech Pharmaceuticals will also deploy WebForce(TM) 1.5 and ForceAnalyzer(TM) for regional managers; ForceAnalyzer(TM) for divisional managers; and ForceAnalyzer(TM), along with ForceAdministrator(TM), for home office users.

Force AnalzeRx(TM) is a flexible, easy-to-use data viewing and analysis tool that standardizes the decision support and reporting process for all levels of a pharmaceutical sales organization. ForceAdministrator(TM) is an interactive territory-management tool that enables pharmaceutical companies to align align (līn),
v to move the teeth into their proper positions to conform to the line of occlusion.
 sales reps to the right customer at the right time with the right product and the right message. It manages product, user, and alignment field force changes.

Pfizer, Colombia, Ecuador, and Venezuela

Pfizer has selected Dendrite's Medicheck(TM) solution for its sales forces in Colombia, Ecuador, and Venezuela. Dendrite will provide locally delivered help desk and technical support directly from Pfizer's facilities in Colombia. Medicheck(TM) is a component of the Dendrite Sales Force Effectiveness solution set that has been developed specifically to meet the needs of pharmaceutical sales forces in Latin America Latin America, the Spanish-speaking, Portuguese-speaking, and French-speaking countries (except Canada) of North America, South America, Central America, and the West Indies. , Asia, Eastern Europe Eastern Europe

The countries of eastern Europe, especially those that were allied with the USSR in the Warsaw Pact, which was established in 1955 and dissolved in 1991.
, and the Middle East.

Sanofi Synthelabo, Argentina, Colombia, Venezuela

Sanofi Synthelabo is rolling out Medicheck(TM) for its sales force in Argentina. Dendrite will provide call center and technical support from its office in Mexico City Mexico City
 Spanish Ciudad de México

City (pop., 2000: city, 8,605,239; 2003 metro. area est., 18,660,000), capital of Mexico. Located at an elevation of 7,350 ft (2,240 m), it is officially coterminous with the Federal District, which occupies 571 sq mi
. In addition, Sanofi Synthelabo has selected Medicheck(TM) for its sales forces in Colombia and Venezuela; rollout will begin in March 2002.

Ashfield Healthcare Ltd., UK

Ashfield Healthcare Ltd., the second-largest provider of pharmaceutical contract sales force resources in the United Kingdom, has doubled its number of WebForce(TM)users as part of an extension of a previously announced multi-year agreement.

About Dendrite

Dendrite, the visionary innovator in global pharmaceutical technology, helps clients strategically manage customer relationships to increase market share. The company creates unique, analytically driven solutions that enable pharmaceutical companies to influence prescriber pre·scribe  
v. pre·scribed, pre·scrib·ing, pre·scribes

v.tr.
1. To set down as a rule or guide; enjoin. See Synonyms at dictate.

2. To order the use of (a medicine or other treatment).
 behavior, thereby delivering a sustained competitive advantage. More than 80,000 pharmaceutical sales representatives pharmaceutical sales representative Detailer, Drug rep Drug industry A drug company employee who regularly visits physicians and office practices, providing information on the company's products–usually putting a negative 'spin' on competitors' products. See Detailing.  and their managers from over 150 companies and 57 countries use Dendrite products and services. They represent 19 of the top 20 pharmaceutical companies. For more information, visit www.dendrite.com.

Media Inquiries

Bob Brody

Ogilvy Public Relations public relations, activities and policies used to create public interest in a person, idea, product, institution, or business establishment. By its nature, public relations is devoted to serving particular interests by presenting them to the public in the most  Worldwide

212-880-5248

Bob.Brody@ogilvypr.com

Note: Dendrite is a registered trademark of Dendrite International, Inc.

The foregoing contains forward-looking statements forward-looking statement

A projected financial statement based on management expectations. A forward-looking statement involves risks with regard to the accuracy of assumptions underlying the projections.
 within the meaning of The Private Securities Litigation Reform Act The Private Securities Litigation Reform Act of 1995 (PSLRA) implemented several significant substantive changes affecting certain cases brought under the federal securities laws, including changes related to pleading, discovery, liability, class representation and awards fees and  of 1995. The statements may be identified by such forward-looking terminology as "expect," "believe," "may," "will," "intend," "plan," and similar statements or variations. Such forward-looking statements are based on our current estimates and assumptions and involve certain significant risks and uncertainties, including: risks associated with and dependence on the pharmaceutical industry; fluctuations in quarterly revenues due to lengthy selling cycles, product implementation cycles, customer budget cycles, and timing of revenue recognition; dependence on major customers; successful and timely development and introduction of new products and versions; rapid technological changes; increased competition; retention of key senior managers; and unique characteristics of the consumer packaged goods Noun 1. packaged goods - groceries that are packaged for sale
foodstuff, grocery - (usually plural) consumer goods sold by a grocer

plural, plural form - the form of a word that is used to denote more than one
 industry. Other important factors that should be considered are included in the company's 10-K, 10-Qs, and other reports filed with the SEC. Actual results may differ materially. The company assumes no obligation for updating any such forward-looking statements.
COPYRIGHT 2001 Business Wire
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 2001, Gale Group. All rights reserved. Gale Group is a Thomson Corporation Company.

 Reader Opinion

Title:

Comment:



 

Article Details
Printer friendly Cite/link Email Feedback
Publication:Business Wire
Geographic Code:1USA
Date:Nov 6, 2001
Words:661
Previous Article:ITI Premier II Platform Version 2.1 Takes Customer Service to the Next Level.
Next Article:Fiserv Advanced Insurance Solutions Outsources Systems for American Skyline Insurance.
Topics:



Related Articles
Dendrite Names Nigel Whitehead Vice President of Global Accounts; Key Walsh/ST Executive Joins SFE Industry Leader Dendrite International.
Dendrite Signs Clinical Trial Agreements with Two Leading Pharmaceutical Companies; Services to Speed Execution and Completion of Each Company's...
Dendrite Signs Global Support Clinical Trial Agreement with Pfizer; Services to Speed Execution and Completion of Clinical Trial Programs.
Dendrite Announces Multi-Country Mid-Tier Business.
Dendrite Opens Representative Office/Wins New Business in China; Shanghai Office To Roll Out Palm-Top Solution For Large European Pharmaceutical...
Dendrite Enters into Serious Adverse Event Reporting Contract with Pfizer Inc.; Multi-Year, Multi-Million-Dollar Contract Covers All Clinical Trials.
Innovative Analytical and Clinical Solutions Propel Dendrite's Growth Strategy; Value of Year to Date Contracts Approaches $35 Million.
Forest Pharmaceuticals Upgrades to Dendrite's WebForce Product Suite.
Aggressive Growth Consolidates Dendrite Leadership in China; Bayer Deploys Dendrite Solution Ahead of Time and on Budget.
Dendrite Extends and Expands Strategic Relationship With Pharmaceutical Giant Bristol-Myers Squibb.

Terms of use | Copyright © 2012 Farlex, Inc. | Feedback | For webmasters | Submit articles